Abstract:Background and Aims The role of vascular smooth muscle cells (SMCs) in atherosclerosis has evolved to indicate causal genetic links with the disease. Single cell RNA sequencing (scRNAseq) studies have identified multiple cell populations of mesenchymal origin within atherosclerotic lesions, including various SMC sub-phenotypes, but it is unknown how they relate to patient clinical parameters and genetics. Here, mesenchymal cell populations in atherosclerotic plaques were correlated with major coronary artery disease (CAD) genetic variants and functional analyses performed to identify SMC markers involved in the disease. Methods Bioinformatic deconvolution was done on bulk microarrays from carotid plaques in the Biobank of Karolinska Endarterectomies (BiKE, n = 125) using public plaque scRNAseq data and associated with patient clinical data and follow-up information. BiKE patients were clustered based on the deconvoluted cell fractions. Quantitative trait loci (QTLs) analyses were performed to predict the effect of CAD associated genetic variants on mesenchymal cell fractions (cfQTLs) and gene expression (eQTLs) in plaques. Results Lesions from symptomatic patients had higher fractions of Type 1 macrophages and pericytes, but lower fractions of classical and modulated SMCs compared with asymptomatic ones, particularly females. Presence of diabetes or statin treatment did not affect the cell fraction distribution. Clustering based on plaque cell fractions, revealed three patient groups, with relative differences in their stability profiles and associations to stroke, even during long-term follow-up. Several single nucleotide polymorphisms associated with plaque mesenchymal cell fractions, upstream of the circadian rhythm gene ARNTL were identified. In vitro silencing of ARNTL in human carotid SMCs increased the expression of contractile markers and attenuated cell proliferation. Conclusions This study shows the potential of combining scRNAseq data with vertically integrated clinical, genetic, and transcriptomic data from a large biobank of human plaques, for refinement of patient vulnerability and risk prediction stratification. The study revealed novel CAD-associated variants that may be functionally linked to SMCs in atherosclerotic plaques. Specifically, variants in the ARNTL gene may influence SMC ratios and function, and its role as a regulator of SMC proliferation should be further investigated.

Abstract 218: Integration Of Coronary Artery Disease GWAS With Bulk And Single-cell Transcriptomics From Atherosclerotic Plaques By Deconvolution, Reveals Novel Smooth Muscle Cell Genes

Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification

Mapping atherogenesis mechanisms in smooth muscle cells by targeting genes linked to coronary artery disease

Abstract 465: Integrative Single-cell Meta-analysis Reveals Disease-relevant Vascular Cell States and Markers in Human Atherosclerosis

Abstract 11993: Integrative Analysis of Single-Cell Transcriptomics and Polygenic Risk Scores Uncovers Vascular Smooth Muscle Cell Heterogeneity in Human Aortic Aneurisms

Genetic Regulation of Atherosclerosis-Relevant Phenotypes in Human Vascular Smooth Muscle Cells

Intersecting single-cell transcriptomics and genome-wide association studies identifies crucial cell populations and candidate genes for atherosclerosis

Comprehensive identification of coronary artery disease-associated variants regulating vascular smooth muscle cell gene expression

Dissecting the effect of genetic variants on atherosclerosis: integrating bulk and single-cell transcriptomics

Secreted protein profiling of human aortic smooth muscle cells identifies vascular disease associations

Abstract MP16: Multi-trait Gwas Of Atherosclerosis Detects Novel Loci And Potential Therapeutic Targets

Single-cell transcriptome-wide Mendelian randomization and colocalization analyses uncover cell-specific mechanisms in atherosclerotic cardiovascular disease

Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human

Abstract 452: Contribution Of Smooth Muscle-derived Vascular Progenitor Cells To Atherosclerosis

Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics

Single-Cell Gene-Regulatory Networks of Advanced Symptomatic Atherosclerosis

High-Dimensional Single-Cell Multimodal Landscape of Human Carotid Atherosclerosis

Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis

Abstract 151: Single Cell Transcriptional and Epigenetic Map of Human Coronary Artery Disease in A Multi-ethnic Population

Single cell variant to enhancer to gene map for coronary artery disease